Vector BioPharma
Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients.
Total raised
€29M
€29,107,506
Funding rounds
1
Investors
0
distinct backers
Active since
2022-08
latest 2022-08
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood35
base rate 44% for Series A
- ▼ Overdue vs cohort gap
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-12 | Series A | €29M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy